{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T19:21:09Z","timestamp":1754162469548,"version":"3.41.2"},"reference-count":52,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.ejps.2012.09.002","type":"journal-article","created":{"date-parts":[[2012,9,13]],"date-time":"2012-09-13T00:08:57Z","timestamp":1347494937000},"page":"781-789","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["A cell penetrating peptide-integrated and enediyne-energized fusion protein shows potent antitumor activity"],"prefix":"10.1016","volume":"47","author":[{"given":"Qin","family":"Ru","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo-yang","family":"Shang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing-fang","family":"Miao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-ying","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui-juan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-su","family":"Zhen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2012.09.002_b0005","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/psc.979","article-title":"Arginine-rich cell penetrating peptides: design, structure-activity, and applications to alter pre-mRNA splicing by steric-block oligonucleotides","volume":"14","author":"Abes","year":"2008","journal-title":"J. Pept. Sci."},{"key":"10.1016\/j.ejps.2012.09.002_b0010","doi-asserted-by":"crossref","first-page":"17450","DOI":"10.1073\/pnas.1114518108","article-title":"Targeted nanoparticle enhanced proapoptotic peptide as potential therapy for glioblastoma","volume":"108","author":"Agemy","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejps.2012.09.002_b0015","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.colsurfb.2010.03.016","article-title":"Reversible polyelectrolyte capsules as carriers for protein delivery","volume":"78","author":"Anandhakumar","year":"2010","journal-title":"Colloids Surf. B Biointerf."},{"key":"10.1016\/j.ejps.2012.09.002_b0020","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/978-1-60761-919-2_26","article-title":"Application of PepFect peptides for the delivery of splice-correcting oligonucleotides","volume":"683","author":"Andaloussi","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ejps.2012.09.002_b0025","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1021\/bc100130r","article-title":"Generation of endosomolytic reagents by branching of cell-penetrating peptides: tools for the delivery of bioactive compounds to live cells in cis or trans","volume":"21","author":"Angeles-Boza","year":"2010","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.ejps.2012.09.002_b0030","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1161\/01.RES.0000269778.75877.68","article-title":"Effect of cell-based intercellular delivery of transcription factor GATA4 on ischemic cardiomyopathy","volume":"100","author":"Bian","year":"2007","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejps.2012.09.002_b0035","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1016\/j.addr.2010.05.003","article-title":"Cell penetrating elastin-like polypeptides for therapeutic peptide delivery","volume":"62","author":"Bidwell","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2012.09.002_b0040","first-page":"232","article-title":"Potential efficacy of cell-penetrating peptides for nucleic acid and drug delivery in cancer","volume":"1816","author":"Bolhassani","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejps.2012.09.002_b0045","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1016\/j.bbamem.2010.09.001","article-title":"Happy birthday cell penetrating peptides: already 20years","volume":"1798","author":"Brasseur","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejps.2012.09.002_b0050","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1049\/iet-syb.2010.0007","article-title":"Cell-penetrating peptides, electroporation and drug delivery","volume":"4","author":"Cahill","year":"2010","journal-title":"IET Syst. Biol."},{"key":"10.1016\/j.ejps.2012.09.002_b0055","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jbiotec.2009.09.001","article-title":"Binding capability of the enediyne-associated apoprotein to human tumors and constitution of a ligand oligopeptide-integrated protein","volume":"144","author":"Cai","year":"2009","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.ejps.2012.09.002_b0060","doi-asserted-by":"crossref","first-page":"8374","DOI":"10.1021\/bi2009079","article-title":"Mechanism of ribonuclease A endocytosis: analogies to cell-penetrating peptides","volume":"50","author":"Chao","year":"2011","journal-title":"Biochemistry (Mosc.)"},{"key":"10.1016\/j.ejps.2012.09.002_b0065","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/cmdc.200500036","article-title":"Conjugation of a photosensitizer to an oligoarginine-based cell-penetrating peptide increases the efficacy of photodynamic therapy","volume":"1","author":"Choi","year":"2006","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejps.2012.09.002_b0070","doi-asserted-by":"crossref","first-page":"10444","DOI":"10.1016\/S0021-9258(17)34080-2","article-title":"The third helix of the Antennapedia homeodomain translocates through biological membranes","volume":"269","author":"Derossi","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejps.2012.09.002_b0075","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1750-3639.2005.tb00115.x","article-title":"Angiogenesis in gliomas: biology and molecular pathophysiology","volume":"15","author":"Fischer","year":"2005","journal-title":"Brain Pathol."},{"key":"10.1016\/j.ejps.2012.09.002_b0080","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1242\/jcs.02460","article-title":"Cationic cell-penetrating peptides interfere with TNF signalling by induction of TNF receptor internalization","volume":"118","author":"Fotin-Mleczek","year":"2005","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.ejps.2012.09.002_b0085","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1021\/bi035933x","article-title":"Pathway for polyarginine entry into mammalian cells","volume":"43","author":"Fuchs","year":"2004","journal-title":"Biochemistry (Mosc.)"},{"key":"10.1016\/j.ejps.2012.09.002_b0090","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.addr.2004.10.007","article-title":"Intracellular delivery of large molecules and small particles by cell-penetrating proteins and peptides","volume":"57","author":"Gupta","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2012.09.002_b0095","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.bbamem.2006.02.012","article-title":"Cell-penetrating peptides \u2013 a brief introduction","volume":"1758","author":"Jarver","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejps.2012.09.002_b0100","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/978-1-60761-919-2_38","article-title":"Therapeutic applications of cell-penetrating peptides","volume":"683","author":"Johnson","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ejps.2012.09.002_b0105","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/15216540500494508","article-title":"Properties of cell penetrating peptides (CPPs)","volume":"58","author":"Kerkis","year":"2006","journal-title":"IUBMB Life"},{"key":"10.1016\/j.ejps.2012.09.002_b0110","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1586\/14737175.8.10.1457","article-title":"Antiangiogenic therapy in brain tumors","volume":"8","author":"Lakka","year":"2008","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.ejps.2012.09.002_b0115","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ijpharm.2011.08.001","article-title":"Distinct transduction modes of arginine-rich cell-penetrating peptides for cargo delivery into tumor cells","volume":"419","author":"Ma","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2012.09.002_b0120","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1517\/13543770802680195","article-title":"Delivery of small-interfering RNA (siRNA) to the brain","volume":"19","author":"Mathupala","year":"2009","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ejps.2012.09.002_b0125","doi-asserted-by":"crossref","first-page":"5344","DOI":"10.1158\/0008-5472.CAN-05-0015","article-title":"The antitumor enediyne C-1027 alters cell cycle progression and induces chromosomal aberrations and telomere dysfunction","volume":"65","author":"McHugh","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejps.2012.09.002_b0130","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/CAD.0b013e3280112779","article-title":"An enediyne-energized single-domain antibody-containing fusion protein shows potent antitumor activity","volume":"18","author":"Miao","year":"2007","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.ejps.2012.09.002_b0135","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1007\/s00705-008-0125-7","article-title":"Cell-permeable artificial zinc-finger proteins as potent antiviral drugs for human papillomaviruses","volume":"153","author":"Mino","year":"2008","journal-title":"Arch. Virol."},{"key":"10.1016\/j.ejps.2012.09.002_b0140","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1034\/j.1399-3011.2000.00723.x","article-title":"Polyarginine enters cells more efficiently than other polycationic homopolymers","volume":"56","author":"Mitchell","year":"2000","journal-title":"J. Pept. Res."},{"key":"10.1016\/j.ejps.2012.09.002_b0145","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1586\/14737175.6.10.1495","article-title":"Advances in strategies to improve drug delivery to brain tumors","volume":"6","author":"Newton","year":"2006","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.ejps.2012.09.002_b0150","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1074\/jbc.M209548200","article-title":"Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake","volume":"278","author":"Richard","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejps.2012.09.002_b0155","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1039\/b503234b","article-title":"Rapid and effective labeling of brain tissue using TAT-conjugated CdS:Mn\/ZnS quantum dots","author":"Santra","year":"2005","journal-title":"Chem. Commun. (Camb.)"},{"key":"10.1016\/j.ejps.2012.09.002_b0160","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/cncr.22741","article-title":"Molecularly targeted therapy for malignant glioma","volume":"110","author":"Sathornsumetee","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.ejps.2012.09.002_b0165","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2174\/1874467210801010050","article-title":"Pharmacology and therapeutic applications of enediyne antitumor antibiotics","volume":"1","author":"Shao","year":"2008","journal-title":"Curr. Mol. Pharmacol."},{"key":"10.1016\/j.ejps.2012.09.002_b0170","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2174\/187152008783497055","article-title":"Enediyne anticancer antibiotic lidamycin: chemistry, biology and pharmacology","volume":"8","author":"Shao","year":"2008","journal-title":"Anticancer Agents Med. Chem."},{"key":"10.1016\/j.ejps.2012.09.002_b0175","doi-asserted-by":"crossref","first-page":"4295","DOI":"10.1073\/pnas.081065198","article-title":"The many ways to cross the plasma membrane","volume":"98","author":"Stephens","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejps.2012.09.002_b0180","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1177\/0022034511424746","article-title":"A cell-permeable fusion protein for the mineralization of human dental pulp stem cells","volume":"91","author":"Suh","year":"2012","journal-title":"J. Dent. Res."},{"key":"10.1016\/j.ejps.2012.09.002_b0185","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/S1359-6446(04)03279-9","article-title":"The use of cell-penetrating peptides for drug delivery","volume":"9","author":"Temsamani","year":"2004","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejps.2012.09.002_b0190","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0022-1759(98)00127-6","article-title":"Highly efficient recovery of functional single-chain Fv fragments from inclusion bodies overexpressed in Escherichia coli by controlled introduction of oxidizing reagent\u2013application to a human single-chain Fv fragment","volume":"219","author":"Tsumoto","year":"1998","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.ejps.2012.09.002_b0195","first-page":"166","article-title":"Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma","volume":"60","author":"Van Meir","year":"2010","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ejps.2012.09.002_b0200","doi-asserted-by":"crossref","first-page":"16010","DOI":"10.1074\/jbc.272.25.16010","article-title":"A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus","volume":"272","author":"Vives","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejps.2012.09.002_b0205","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/nm996","article-title":"Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis","volume":"10","author":"Wadia","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejps.2012.09.002_b0210","doi-asserted-by":"crossref","first-page":"13003","DOI":"10.1073\/pnas.97.24.13003","article-title":"The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters","volume":"97","author":"Wender","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejps.2012.09.002_b0215","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/BF00689274","article-title":"Mode of action of C-1027, a new macromolecular antitumor antibiotic with highly potent cytotoxicity, on human hepatoma BEL-7402 cells","volume":"27","author":"Xu","year":"1990","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ejps.2012.09.002_b0220","doi-asserted-by":"crossref","first-page":"5947","DOI":"10.1021\/bi00185a036","article-title":"C1027 chromophore, a potent new enediyne antitumor antibiotic, induces sequence-specific double-strand DNA cleavage","volume":"33","author":"Xu","year":"1994","journal-title":"Biochemistry (Mosc.)"},{"key":"10.1016\/j.ejps.2012.09.002_b0225","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/nbt843","article-title":"Nanoparticles for the delivery of genes and drugs to human hepatocytes","volume":"21","author":"Yamada","year":"2003","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ejps.2012.09.002_b0230","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/jbm.a.31331","article-title":"Intracellular delivery enhancement of poly(amino acid) drug carriers by oligoarginine conjugation","volume":"86","author":"Yang","year":"2008","journal-title":"J. Biomed. Mater. Res. A"},{"key":"10.1016\/j.ejps.2012.09.002_b0235","first-page":"111","article-title":"SKOV-3 cell imaging by paramagnetic particles labeled with hairpin cell-penetrating peptides","volume":"124","author":"Zhai","year":"2011","journal-title":"Chin. Med. J. (Engl.)"},{"key":"10.1016\/j.ejps.2012.09.002_b0240","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1007\/s11033-010-0406-6","article-title":"A novel human derived cell-penetrating peptide in drug delivery","volume":"38","author":"Zhao","year":"2011","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.ejps.2012.09.002_b0245","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.7164\/antibiotics.42.1294","article-title":"A new macromolecular antitumor antibiotic, C-1027. III. Antitumor activity","volume":"42","author":"Zhen","year":"1989","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1016\/j.ejps.2012.09.002_b0250","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/aps.2009.75","article-title":"Lidamycin shows highly potent cytotoxic to myeloma cells and inhibits tumor growth in mice","volume":"30","author":"Zhen","year":"2009","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejps.2012.09.002_b0255","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.canlet.2010.02.020","article-title":"A tandem scFv-based fusion protein and its enediyne-energized analogue show intensified therapeutic efficacy against lung carcinoma xenograft in athymic mice","volume":"295","author":"Zhong","year":"2010","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejps.2012.09.002_b0260","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.addr.2004.10.010","article-title":"Cell-penetrating peptides: mechanism and kinetics of cargo delivery","volume":"57","author":"Zorko","year":"2005","journal-title":"Adv. Drug Deliv. Rev."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098712003417?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098712003417?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T06:22:24Z","timestamp":1753856544000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098712003417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":52,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S0928098712003417"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2012.09.002","relation":{},"ISSN":["0928-0987"],"issn-type":[{"type":"print","value":"0928-0987"}],"subject":[],"published":{"date-parts":[[2012,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A cell penetrating peptide-integrated and enediyne-energized fusion protein shows potent antitumor activity","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2012.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}